Article Versions Notes

Iradyan M, Iradyan N, Hulin P, Hambardzumyan A, Gyulkhandanyan A, Alves de Sousa R, Hessani A, Roussakis C, Bollot G, Bauvais C, et al. Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death. Cancers. 2019; 11(8):1094. https://doi.org/10.3390/cancers11081094

Iradyan, Melkon, Nina Iradyan, Philippe Hulin, Artur Hambardzumyan, Aram Gyulkhandanyan, Rodolphe Alves de Sousa, Assia Hessani, Christos Roussakis, Guillaume Bollot, Cyril Bauvais, and et al. 2019. "Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death" Cancers 11, no. 8: 1094. https://doi.org/10.3390/cancers11081094

Iradyan, M., Iradyan, N., Hulin, P., Hambardzumyan, A., Gyulkhandanyan, A., Alves de Sousa, R., Hessani, A., Roussakis, C., Bollot, G., Bauvais, C., & Sakanyan, V. (2019). Targeting Degradation of EGFR through the Allosteric Site Leads to Cancer Cell Detachment-Promoted Death. Cancers, 11(8), 1094. https://doi.org/10.3390/cancers11081094